Osiris Therapeutics (OSIR) to be Acquired by Smith & Nephew (SNN) for $19/Share

March 12, 2019 9:02 AM
Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Hot Corp. News Hot M&A Mergers and Acquisitions Trading Halts

Next Articles